↓ Skip to main content

Low PTEN expression is associated with worse overall survival in head and neck squamous cell carcinoma patients treated with chemotherapy and cetuximab

Overview of attention for article published in International Journal of Clinical Oncology, May 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
20 Mendeley
Title
Low PTEN expression is associated with worse overall survival in head and neck squamous cell carcinoma patients treated with chemotherapy and cetuximab
Published in
International Journal of Clinical Oncology, May 2014
DOI 10.1007/s10147-014-0707-1
Pubmed ID
Authors

Alexandre A. B. A. da Costa, Felipe D’Almeida Costa, Adriana R. Ribeiro, Andréia P. Guimarães, Ludmila T. Chinen, Clóvis A. P. Lopes, Vladmir C. C. de Lima

Abstract

Platinum-based chemotherapy associated with cetuximab is the first-line treatment for inoperable recurrence or metastatic head and neck squamous cell carcinoma (HNSCC). There is no established biomarker for cetuximab efficacy in HNSCC. The PI3K pathway is one of the most frequently altered pathways in HNSCC. Loss of phosphatase and tensin homolog (PTEN) expression occurs in up to 30 % of cases.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Tanzania, United Republic of 1 5%
Unknown 19 95%

Demographic breakdown

Readers by professional status Count As %
Other 4 20%
Student > Ph. D. Student 3 15%
Student > Bachelor 3 15%
Researcher 2 10%
Professor > Associate Professor 2 10%
Other 6 30%
Readers by discipline Count As %
Medicine and Dentistry 13 65%
Agricultural and Biological Sciences 5 25%
Biochemistry, Genetics and Molecular Biology 1 5%
Unspecified 1 5%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2014.
All research outputs
#7,638,453
of 12,223,436 outputs
Outputs from International Journal of Clinical Oncology
#346
of 788 outputs
Outputs of similar age
#99,953
of 197,672 outputs
Outputs of similar age from International Journal of Clinical Oncology
#10
of 22 outputs
Altmetric has tracked 12,223,436 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 788 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 197,672 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.